Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)

NCT04243278 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Poor Recruitment Rates

Conditions

Preeclampsia Severe
Cardiovascular Diseases
Primary Prevention

Interventions

DRUG: Low-dose aspirin
DRUG: Placebo oral tablet

Sponsor

Dr. Graeme Smith